← Back to Search

Behavioral Intervention for HIV/AIDS Prevention in Black MSM

N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Identifies as biologically male
Minimally 18 years and 0 months of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a behavioral intervention to promote HIV testing, education, support, and referral for pre-exposure prophylaxis in young black men who have sex with men in order to address the HIV crisis in Alabama.

Who is the study for?
This trial is for Black young men (18-29 years old) in Alabama who have sex with other men, can speak and read English, are sexually active, and either conduct or oversee community outreach and HIV testing. They must be willing to give informed consent.
What is being tested?
The study is testing a behavioral intervention called Adapted Brothers Saving Brothers (aBSB), compared to standard street outreach methods. The goal is to increase HIV rapid testing, provide prevention education, support services, and refer eligible individuals for PrEP.
What are the potential side effects?
Since this trial focuses on a behavioral intervention rather than medication, there may not be direct physical side effects. However, participants might experience stress or discomfort discussing personal behaviors related to HIV prevention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am biologically male.
Select...
I am at least 18 years old.
Select...
I am between 18 and 29 years old.
Select...
I am a man who has sex with men.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability as assessed by participant self-rated satisfaction with the intervention
Did the study participant accept a community-based rapid HIV test after the delivery of the aBSB or standard outreach intervention?
Secondary study objectives
Did the study participant secure a prescription for PrEP?

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: aBSBExperimental Treatment1 Intervention
aBSB is the adaptation of BSB. BSB a two part intervention to improve rates of community-based HIV testing and prevention education in black young MSM (YMSM). BSB was developed on Information Motivation Behavioral Skills (IMB) theory. The first part of BSB uses Motivational Interviewing in a culturally appropriate way to encourage participants to accept testing and return for test results. The second part is conducted after the participant has received his result, assuming it was not reactive and offers prevention education.
Group II: Street OutreachActive Control1 Intervention
Standard street outreach was used as the control in the original BSB trial.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,206 Total Patients Enrolled
Florida State UniversityLead Sponsor
224 Previous Clinical Trials
36,474 Total Patients Enrolled
University of California, San FranciscoOTHER
2,593 Previous Clinical Trials
14,887,783 Total Patients Enrolled

Media Library

Adapted Brothers Saving Brothers (aBSB) Clinical Trial Eligibility Overview. Trial Name: NCT03680729 — N/A
HIV/AIDS Research Study Groups: aBSB, Street Outreach
HIV/AIDS Clinical Trial 2023: Adapted Brothers Saving Brothers (aBSB) Highlights & Side Effects. Trial Name: NCT03680729 — N/A
Adapted Brothers Saving Brothers (aBSB) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03680729 — N/A
~3 spots leftby Jan 2025